Riskpilot← Back to searchSign inGet full accessSPERMATECH AS
ASActiveOrg 984698542.etg. Oppgang B 5, 0372 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20023 employees
Revenue 2024
NOK 2,7M
-1% vs 2023
EBITDA margin
-1.5%
+83% vs 2023
Equity ratio
-2.2%
Financial strength
Net profit 2024
NOK -1,2M
+14% vs 2023
| Revenue | NOK 2,7M | -1% |
| EBITDA | NOK -42K | +83% |
| Net profit | NOK -1,2M | +14% |
| Total assets | NOK 1,4M | -42% |
| Equity | NOK -32K | -103% |
| Employees | 3 | — |
Legal name
SPERMATECH AS
Org number
984698542
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. august 2002
Share capital
NOK 243 804
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap, eller daglig leder sammen med to styremedlemmer.
Company purpose
Utvikle og kommersialisere teknologi i tilknytning til c@s og andre substanser som kan påvirke kroppens funksjoner og drive økonomisk virksomhet i tilknytning til dette.
Address
.etg. Oppgang B 5, 0372 Oslo
Phone
+4722147087
Email
mail@spermatech.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 087 | 7 244 | 4 319 | 2 764 | 720 | 5 276 | 6 032 | 4 793 | 1 939 | 2 013 | 4 141 | 2 453 | 3 625 | 2 601 | 3 746 | 2 715 | 2 697 |
| Staff expenses | −2 115 | −2 277 | −2 237 | −2 517 | −1 935 | −1 812 | −2 848 | −3 048 | −1 938 | −854 | −1 795 | 1 141 | 846 | −1 389 | −1 918 | −955 | −1 418 |
| EBITDA | −6 665 | 1 001 | −1 645 | −1 003 | −1 742 | 1 427 | 500 | −617 | −1 466 | −205 | 359 | 2 248 | 3 126 | 526 | −139 | −239 | −42 |
| Depreciation & amort. | −193 | −169 | −88 | −14 | −23 | −24 | −18 | −27 | −31 | −31 | −31 | −31 | −853 | −1 205 | −1 205 | −1 205 | −1 205 |
| EBIT | −6 858 | 832 | −1 733 | −1 017 | −1 765 | 1 403 | 483 | −644 | −1 497 | −236 | 328 | 2 217 | 2 274 | −679 | −1 344 | −1 445 | −1 247 |
| Net financials | 209 | 240 | 71 | 44 | 6 | 5 | 9 | 4 | 6 | −14 | −0 | −1 | 4 | −2 | −4 | −2 | −2 |
| Profit before tax | −6 648 | 1 072 | −1 662 | −973 | −1 759 | 1 408 | 492 | −640 | −1 491 | −251 | 327 | 2 216 | 2 277 | −681 | −1 348 | −1 447 | −1 249 |
| Tax | −2 337 | 4 044 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −4 311 | −2 972 | −1 662 | −973 | −1 759 | 1 408 | 492 | −640 | −1 491 | −251 | 327 | 2 216 | 2 277 | −681 | −1 348 | −1 447 | −1 249 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9 837 | 6 008 | 4 065 | 3 160 | 854 | 3 747 | 4 037 | 3 534 | 2 150 | 1 177 | 1 677 | 4 306 | 6 766 | 5 492 | 4 610 | 2 507 | 1 445 |
| Equity | 7 718 | 4 746 | 3 084 | 2 111 | 352 | 1 761 | 2 252 | 1 613 | 122 | −129 | 198 | 2 415 | 4 692 | 4 011 | 2 663 | 1 217 | −32 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 119 | 1 262 | 981 | 1 049 | 501 | 1 986 | 1 784 | 1 921 | 2 029 | 1 306 | 1 479 | 1 342 | 1 141 | 723 | 1 419 | 1 290 | 1 478 |
| Total debt | 2 119 | 1 262 | 981 | 1 049 | 501 | 1 986 | 1 784 | 1 921 | 2 029 | 1 306 | 1 479 | 1 342 | 1 141 | 723 | 1 419 | 1 290 | 1 478 |
EBITDA margin
-1.5%
This company
15.8%
Market median
-109% vs market
20082024
Equity ratio
-2.2%
This company
38.2%
Market median
-106% vs market
20082024
Return on equity
-124892900.0%
This company
18.4%
Market median
-678765861% vs market
20082024
Net profit margin
-46.3%
This company
8.1%
Market median
-672% vs market
20082024
Asset turnover
1.87×
This company
1.12×
Market median
+67% vs market
20082024
Debt / equity
45.61×
This company
0.62×
Market median
-7256% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EM Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Skilling Systemer As | Company | 18.7% | 18.7% | 2022 |
| Individual | 10.7% | 10.7% | 2022 | |
Ojada As | Company | 10.3% | 10.3% | 2022 |
Solan Capital As | Company | 9.3% | 9.3% | 2022 |
| Individual | 6.3% | 6.3% | 2022 | |
| Individual | 5.8% | 5.8% | 2022 | |
| Individual | 4.2% | 4.2% | 2022 | |
| Individual | 3.4% | 3.4% | 2022 | |
Vipz As | Company | 3.2% | 3.2% | 2022 |
Nyholt As | Company | 2.9% | 2.9% | 2022 |
Herikla As | Company | 2.9% | 2.9% | 2022 |
Oslotech As | Company | 2.9% | 2.9% | 2022 |
| Individual | 2.6% | 2.6% | 2022 | |
| Individual | 2.6% | 2.6% | 2022 | |
| Individual | 2.3% | 2.3% | 2022 | |
| Individual | 2.2% | 2.2% | 2022 | |
| Individual | 1.5% | 1.5% | 2022 | |
| Individual | 1.2% | 1.2% | 2022 | |
| Individual | 1.2% | 1.2% | 2022 | |
C. Emtor Eiendom As | Company | 1.1% | 1.1% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SPERMATECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Espen Marcelius Gjems | Chief Executive Officer | 0 companies |
| Eirik Næss-Ulseth | Chairman | 0 companies |
| Gunnar Hvammen | Board of Directors | 0 companies |